Medical Weight Loss Treatment for Wisconsin Residents
Medically Supervised Weight Loss, Delivered Online
OmniRx Health providers are licensed by the Wisconsin Medical Examining Board for comprehensive statewide telehealth services.
Whether you're in Milwaukee, Madison, or anywhere across Wisconsin — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in Wisconsin
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
Wisconsin's hardworking people deserve healthcare that fits their lifestyle. From the breweries of Milwaukee to the government center of Madison, the manufacturing towns along Lake Michigan to the dairy farms of the Driftless Region, OmniRx Health serves all of America's Dairyland. Our telehealth platform understands Wisconsin values—no-nonsense, quality care delivered efficiently, whether you're in a major city or a small town.
Available Treatments in Wisconsin
Our board-certified providers in Wisconsin can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in Wisconsin
State Licensing
OmniRx Health providers are licensed by the Wisconsin Medical Examining Board for comprehensive statewide telehealth services.
Telehealth Law
Wisconsin has telehealth laws that support virtual care delivery while maintaining quality standards for patient safety.
Pharmacy Access
Wisconsin pharmacies in Milwaukee, Madison, Green Bay, and throughout the state provide prescription services with reliable delivery.
Insurance Notes
Wisconsin insurers cover telehealth services, with ongoing efforts to expand access and ensure fair reimbursement.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in Wisconsin
Explore Related Medical Weight Loss Pages
Direct links to specific treatments, other services, and every state we serve.